Advanced search
Publication Cover
Expert Review of Gastroenterology & Hepatology Volume 13, 2019 - Issue 1
Submit an article Journal homepage
73
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Ritonavir-boosted paritaprevir, ombitasvir plus ribavirin could improve eGFR in patients with renal impairment and HCV: an Egyptian cohort

Mohamed SaidEndemic Medicine and Hepato-gastroenterology Department, Faculty of Medicine, Cairo University, Cairo, EgyptView further author information
,
Heba OmarEndemic Medicine and Hepato-gastroenterology Department, Faculty of Medicine, Cairo University, Cairo, EgyptCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-9707-1141View further author information
ORCID Icon,
Zeinab SolimanEndemic Medicine and Hepato-gastroenterology Department, Faculty of Medicine, Cairo University, Cairo, EgyptView further author information
,
Yasmin SaadEndemic Medicine and Hepato-gastroenterology Department, Faculty of Medicine, Cairo University, Cairo, EgyptView further author information
,
Hosam DabesInternal Medicine Department, Damanhour Medical National Institute, Damanhour, EgyptView further author information
,
Sozan HamedInternal Medicine Department, Damanhour Medical National Institute, Damanhour, EgyptView further author information
,
Kadri ElSaeedInternal Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, EgyptView further author information
,
Yehia ElShazlyInternal Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, EgyptView further author information
&
Magdi ElSerafyEndemic Medicine and Hepato-gastroenterology Department, Faculty of Medicine, Cairo University, Cairo, EgyptView further author information
 show all
Pages 89-93 | Received 03 Aug 2018, Accepted 31 Oct 2018, Published online: 13 Nov 2018

References

  • World Health Organization. Global Hepatitis Report. 2017. Available from: http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/
  • Dammacco F, Sansonno D. Therapy for hepatitis C virus-related cryoglobulinemic vasculitis. N Engl J Med. 2013;369:1035–1045.
  • Lens S, Rodriguez-Tajes S, Llovet LP, et al. Treating hepatitis C in patients with renal failure. Dig Dis. 2017;35(4):339–346. Epub 2017 May 3.
  • Ridruejo E, Diaz C, Michel MD, et al. Short and long term outcome of kidney transplanted patients with chronic viral hepatitis B and C. Ann Hepatol. 2010;9:271–277.
  • Goodkin DA, Bieber B, Gillespie B, et al. Hepatitis C infection is very rarely treated among hemodialysis patients. Am J Nephrol. 2013;38:405–412.
  • hcvguidelines.org [homepage on the Internet]. Initial treatment of hcv infection. American Association for the Study of Liver Diseases and the Infectious Diseases Society of America. [updated 2017 Sep 21; cited 2017 Dec 22]. Available from: http://www.hcvguidelines.org/full-report/initial-treatment-hcv-infection
  • AbbVie Corporation. Product monograph including patient medication information PrHOLKIRA™ PAK. AbbVie corporation. 2016. [cited 2017 Dec 22]. Available from: http://www.abbvie.ca/content/dam/abbviecorp/ca/english/docs/HOLKIRA_PAK_PM_EN.pd
  • Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modifi cation of diet in renal disease study equation for estimating glomerular fi ltration rate. Ann Intern Med. 2006;145:247–254.
  • de Lédinghen V, Vergniol J. Transient elastography (FibroScan). Gastroenterol Clin Biol. 2008 Sep;32(6 Suppl 1):58–67..
  • EASL. Recommendations on treatment of hepatitis C 2016. European Association for the Study of the Liver. J Hepatol. 2017 Jan;66(1):153–194.
  • U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS. Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events, Version 2.0. [ cited 2014 Nov]. Available from: http://rsc.tech-res.com/docs/default-source/safety/daids_ae_grading_table_v2_nov2014.pdf
  • Recommendations for Testing, Managing, and Treating Hepatitis C. Joint panel from the American Association of the Study of Liver Diseases and the Infectious Diseases Society of America. [cited 2017 Dec 24]. Available from: http://www.hcvguidelines.org/
  • Brennan BJ, Wang K, Blotner S, et al. Safety, tolerability, and pharmacokinetics of ribavirin in hepatitis C virus-infected patients with various degrees of renal impairment. Antimicrob Agents Chemother. 2013;57(12):6097–6105.
  • Guidance HC. Update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection. AASLD-IDSA HCV guidance panel. Clin Infect Dis. 2018 Sep 12; DOI:10.1093/cid/ciy585. Epub ahead of print.
  • Mekky MA, Abdel-Malek MO, Osman HA, et al. Efficacy of ombitasvir/paritaprevir/ritonavir/ribavirin in management of HCV genotype 4 and end-stage kidney disease. Clin Res Hepatol Gastroenterol. 2018 Aug 27; S2210-7401(18)30147-5. DOI:10.1016/j.clinre.2018.08.003.
  • Pockros PJ, Reddy KR, Mantry PS, et al. Efficacy of direct-acting antiviral combination for patients with hepatitis C virus genotype 1 infection and severe renal impairment or end-stage renal disease. Gastroenterology. 2016 Jun; 150(7):1590–1598.
  • Roth D, Nelson DR, Bruchfeld A, et al. Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study. Lancet. 2015 Oct 17; 386(10003):1537–1545.
  • Gane E, Lawitz E, Pugatch D, et al. Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment. N Engl J Med. 2017;377(15):1448.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.